1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 25,000 Shares

November 16, 2009 | About:

President and CEO, 10% Owner of Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) Patrick J Mcenany buys 25,000 shares of CPRX on 11/16/2009 at an average price of $0.75 a share.

CATALYST PHARMACEUTICAL PARTNERS, INC. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for Brookhaven's patent portfolio in the US relating to the right to use vigabatrin to treat a wide variety of substance addictions and obsessive compulsive disorders. Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending worldwide. The Company's initial product candidate based on vigabatrin is CPP-109. CPP-109 has been granted `Fast Track` status by the U.S. Food & Drug Administration for the treatment of cocaine addiction. This indicates that the FDA has recognized that CPP-109 is intended for the treatment of a serious or life-threatening condition for which there is no effective treatment and which demonstrates the potential t Catalyst Pharmaceutical Partners Inc. has a market cap of $9.85 million; its shares were traded at around $0.7 .

Insiders' Positions with CPRX



  • Buy:: Director Milton J Wallace bought 100 shares of CPRX stock on 05/22/2009 at the average price of 2.06, the price of the stock has decreased by 66.02% since


  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 2.5/5 (2 votes)

Comments

Please leave your comment:


GuruFocus has detected 1 Warning Sign with Catalyst Pharmaceuticals Inc $CPRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

Performances of the stocks mentioned by insider


User Generated Screeners


pbarker46Cdn E & P
DANGORDONRETURN ON EQ 4-29-17
erilasDividendstrategie
HOLKLSUTake 5 Group Low Downside Cont
New MoonSmall Cap High ROIC
DANGORDONBOOK VAL GR 4-29-17
dvnrravinidhi_ev_ebitda
Roger SteraHEALTHY GROWTH
Roger SteraSmall Quality
Roger SteraEPS GROWTH 4-28-17
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK